FDA Adverse Event Injury Summary report: N

WEB LOW PROFILE SL-USA W4-5-3FOR US

MDR report key: 10411630 · Received August 14, 2020

Report

Report Number
2032493-2020-00208
Event Type
Injury
Date Received
August 14, 2020
Date of Event
July 16, 2020
Report Date
July 17, 2020
Manufacturer
SEQUENT MEDICAL, INC.
Product Code
OPR
UDI-DI
00854111006068
PMA / PMN Number
P170023
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE MANUFACTURING RECORDS WERE REVIEWED. ALL INSPECTION VALUES WERE WITHIN SPECIFICATION AND THERE WERE NO NCR'S OR DEVIATIONS. THE WEB WAS IMPLANTED AND THE DELIVERY SYSTEM WAS NOT RETURNED FOR EVALUATION. THE ROOT CAUSE CANNOT BE DETERMINED. THE INSTRUCTIONS FOR USE (IFU) IDENTIFIES PARENT ARTERY OCCLUSION, VASCULAR THROMBOSIS, NEUROLOGIC DEFICITS, AND DEVICE MIGRATION OR MISPLACEMENT AS POTENTIAL COMPLICATIONS ASSOCIATED WITH USE OF THE DEVICE.

Description of Event or Problem · 1

IT WAS REPORTED THAT AFTER THE WEB WAS IMPLANTED IN AN ACOM ANEURYSM, THE DEVICE PROTRUDED INTO THE PARENT ARTERY APPROXIMATELY 40-50%; HOWEVER, THE A2 WAS FILLING NICELY. AFTER THE PATIENT WOKE UP POST-PROCEDURE, HE HAD RIGHT SIDED WEAKNESS THAT WORSENED. THE PATIENT WAS BROUGHT BACK TO THE ANGIO SUITE AND ANGIOGRAPHY DEMONSTRATED CLOT ON THE WEB THAT EXTENDED INTO THE A2. TPA WAS DELIVERED TO THE PATIENT, WHICH DISSOLVED THE CLOT. FINAL ANGIOGRAMS LOOKED GOOD. POST-OPERATIVELY, THE PATIENT WAS PLACED ON A HEPARIN DRIP AND PRESCRIBED ASPIRIN AND PLAVIX. THERE WAS NO SEQUELA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
872360 WEB LOW PROFILE SL-USA W4-5-3FOR US INTRASACCULAR FLOW DISRUPTION DEVICE OPR SEQUENT MEDICAL, INC. FGA25050-030 20022612X 00854111006068

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention